Form D Cersci Therapeutics Inc.

Notice of Exempt Offering of Securities, item 06b

Published: 2019-10-07 19:41:04
Submitted: 2019-10-08
Period Ending In: 2019-10-08
primary_doc.html


>

SEC FORM D

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM D

Notice of Exempt Offering of Securities

OMB APPROVAL
OMB Number: 3235-0076
Estimated average burden
hours per response: 4.00

1. Issuer's Identity

CIK (Filer ID Number) Previous Names
X None
Entity Type
0001790478
X Corporation
   Limited Partnership
   Limited Liability Company
   General Partnership
   Business Trust
   Other (Specify)

Name of Issuer
CerSci Therapeutics Inc.
Jurisdiction of Incorporation/Organization
DELAWARE
Year of Incorporation/Organization
   Over Five Years Ago
X Within Last Five Years (Specify Year) 2019
   Yet to Be Formed

2. Principal Place of Business and Contact Information

Name of Issuer
CerSci Therapeutics Inc.
Street Address 1 Street Address 2
17217 WATERVIEW PARKWAY SUITE 1.202
City State/Province/Country ZIP/PostalCode Phone Number of Issuer
DALLAS TEXAS 75252 2143066218

3. Related Persons

Last Name First Name Middle Name
Rodriguez Lucas
Street Address 1 Street Address 2
17217 Waterview Parkway Suite 1.202
City State/Province/Country ZIP/PostalCode
Dallas TEXAS 75252
Relationship:    Executive Officer X Director    Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Brous Tyler
Street Address 1 Street Address 2
3889 Maple Avenue, Suite 125
City State/Province/Country ZIP/PostalCode
Dallas TEXAS 75219
Relationship:    Executive Officer X Director    Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Dax Scott
Street Address 1 Street Address 2
3 Quail Drive
City State/Province/Country ZIP/PostalCode
Landenberg PENNSYLVANIA 19350
Relationship:    Executive Officer X Director    Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Genecov David
Street Address 1 Street Address 2
11970 North Central Expressway Suite 270
City State/Province/Country ZIP/PostalCode
Dallas TEXAS 75243
Relationship:    Executive Officer X Director    Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Hitt II David
Street Address 1 Street Address 2
4237 Helmsley Ln
City State/Province/Country ZIP/PostalCode
Plano TEXAS 75093
Relationship:    Executive Officer X Director    Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Robbins Dennis
Street Address 1 Street Address 2
1104 Morningstar Trail
City State/Province/Country ZIP/PostalCode
Richardson TEXAS 75081
Relationship:    Executive Officer X Director    Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Confalone Pat
Street Address 1 Street Address 2
303 Centennial Circle
City State/Province/Country ZIP/PostalCode
Wilmington DELAWARE 19807
Relationship:    Executive Officer X Director    Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Duncan Brent
Street Address 1 Street Address 2
2710 Sir Bedivere Ln
City State/Province/Country ZIP/PostalCode
Lewisville TEXAS 75056
Relationship:    Executive Officer X Director    Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Harkey, Jr. John D.
Street Address 1 Street Address 2
12200 North Stemmons Freeway Suite 100
City State/Province/Country ZIP/PostalCode
Dallas TEXAS 75234
Relationship:    Executive Officer X Director    Promoter

Clarification of Response (if Necessary):


Last Name First Name Middle Name
Molinoff Perry
Street Address 1 Street Address 2
10 Blue Heron Pond Rd
City State/Province/Country ZIP/PostalCode
Johns Island SOUTH CAROLINA 29455
Relationship:    Executive Officer X Director    Promoter

Clarification of Response (if Necessary):


4. Industry Group

   Agriculture
Banking & Financial Services
   Commercial Banking
   Insurance
   Investing
   Investment Banking
   Pooled Investment Fund
Is the issuer registered as
an investment company under
the Investment Company
Act of 1940?
   Yes    No
   Other Banking & Financial Services
   Business Services
Energy
   Coal Mining
   Electric Utilities
   Energy Conservation
   Environmental Services
   Oil & Gas
   Other Energy
Banking & Financial Services
   Biotechnology
   Health Insurance
   Hospitals & Physicians
X Pharmaceuticals
   Other Health Care
   Manufacturing
Banking & Financial Services
   Commercial
   Construction
   REITS & Finance
   Residential
   Other Real Estate
Retailing
Restaurants
Banking & Financial Services
   Computers
   Telecommunications
   Other Technology
Banking & Financial Services
   Airlines & Airports
   Lodging & Conventions
   Tourism & Travel Services
   Other Travel
Other

5. Issuer Size

Revenue Range OR Aggregate Net Asset Value Range
   No Revenues    No Aggregate Net Asset Value
   $1 - $1,000,000    $1 - $5,000,000
   $1,000,001 - $5,000,000    $5,000,001 - $25,000,000
   $5,000,001 - $25,000,000    $25,000,001 - $50,000,000
   $25,000,001 - $100,000,000    $50,000,001 - $100,000,000
   Over $100,000,000    Over $100,000,000
X Decline to Disclose    Decline to Disclose
   Not Applicable    Not Applicable

6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)

   Rule 504(b)(1) (not (i), (ii) or (iii))
   Rule 504 (b)(1)(i)
   Rule 504 (b)(1)(ii)
   Rule 504 (b)(1)(iii)
X Rule 506(b)
   Rule 506(c)
   Securities Act Section 4(a)(5)
   Investment Company Act Section 3(c)
   Section 3(c)(1)    Section 3(c)(9)  
   Section 3(c)(2)    Section 3(c)(10)
   Section 3(c)(3)    Section 3(c)(11)
   Section 3(c)(4)    Section 3(c)(12)
   Section 3(c)(5)    Section 3(c)(13)
   Section 3(c)(6)    Section 3(c)(14)
   Section 3(c)(7)

7. Type of Filing

X New Notice Date of First Sale 2019-04-04    First Sale Yet to Occur
   Amendment

8. Duration of Offering

Does the Issuer intend this offering to last more than one year?
   Yes X No

9. Type(s) of Securities Offered (select all that apply)

X Equity    Pooled Investment Fund Interests
   Debt    Tenant-in-Common Securities
   Option, Warrant or Other Right to Acquire Another Security    Mineral Property Securities
   Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security    Other (describe)

10. Business Combination Transaction

Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer?
   Yes X No

Clarification of Response (if Necessary):

11. Minimum Investment

Minimum investment accepted from any outside investor $600 USD

12. Sales Compensation

Recipient
Recipient CRD Number X None
(Associated) Broker or Dealer X None
(Associated) Broker or Dealer CRD Number X None
Street Address 1 Street Address 2
City State/Province/Country ZIP/Postal Code
State(s) of Solicitation (select all that apply)
Check “All States” or check individual States
   All States
   Foreign/non-US

13. Offering and Sales Amounts

Total Offering Amount $8,000,000 USD
or    Indefinite
Total Amount Sold $8,000,000 USD
Total Remaining to be Sold $0 USD
or    Indefinite

Clarification of Response (if Necessary):

14. Investors

  
Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors, and enter the number of such non-accredited investors who already have invested in the offering.
Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering:
24

15. Sales Commissions & Finder's Fees Expenses

Provide separately the amounts of sales commissions and finders fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.

Sales Commissions $0 USD
   Estimate
Finders' Fees $0 USD
   Estimate

Clarification of Response (if Necessary):

16. Use of Proceeds

Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.

$0 USD
   Estimate

Clarification of Response (if Necessary):

Signature and Submission

Please verify the information you have entered and review the Terms of Submission below before signing and clicking SUBMIT below to file this notice.

Terms of Submission

In submitting this notice, each issuer named above is:
  • Notifying the SEC and/or each State in which this notice is filed of the offering of securities described and undertaking to furnish them, upon written request, in the accordance with applicable law, the information furnished to offerees.*
  • Irrevocably appointing each of the Secretary of the SEC and, the Securities Administrator or other legally designated officer of the State in which the issuer maintains its principal place of business and any State in which this notice is filed, as its agents for service of process, and agreeing that these persons may accept service on its behalf, of any notice, process or pleading, and further agreeing that such service may be made by registered or certified mail, in any Federal or state action, administrative proceeding, or arbitration brought against the issuer in any place subject to the jurisdiction of the United States, if the action, proceeding or arbitration (a) arises out of any activity in connection with the offering of securities that is the subject of this notice, and (b) is founded, directly or indirectly, upon the provisions of:  (i) the Securities Act of 1933, the Securities Exchange Act of 1934, the Trust Indenture Act of 1939, the Investment Company Act of 1940, or the Investment Advisers Act of 1940, or any rule or regulation under any of these statutes, or (ii) the laws of the State in which the issuer maintains its principal place of business or any State in which this notice is filed.
  • Certifying that, if the issuer is claiming a Regulation D exemption for the offering, the issuer is not disqualified from relying on Rule 504 or Rule 506 for one of the reasons stated in Rule 504(b)(3) or Rule 506(d).

Each Issuer identified above has read this notice, knows the contents to be true, and has duly caused this notice to be signed on its behalf by the undersigned duly authorized person.

For signature, type in the signer's name or other letters or characters adopted or authorized as the signer's signature.

Issuer Signature Name of Signer Title Date
CerSci Therapeutics Inc. Lucas Rodriguez Lucas Rodriguez Chief Executive Officer of Issuer 2019-10-07

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.

* This undertaking does not affect any limits Section 102(a) of the National Securities Markets Improvement Act of 1996 ("NSMIA") [Pub. L. No. 104-290, 110 Stat. 3416 (Oct. 11, 1996)] imposes on the ability of States to require information. As a result, if the securities that are the subject of this Form D are "covered securities" for purposes of NSMIA, whether in all instances or due to the nature of the offering that is the subject of this Form D, States cannot routinely require offering materials under this undertaking or otherwise and can require offering materials only to the extent NSMIA permits them to do so under NSMIA's preservation of their anti-fraud authority.


primary_doc.xml
Schema Version:
X0708
Submission Type:
D
Test Or Live:
LIVE

Primary Issuer

Cik
0001790478
Entity Name
CerSci Therapeutics Inc.

Issuer Address

Street1
17217 WATERVIEW PARKWAY SUITE 1.202
City
DALLAS
State Or Country
TX
State Or Country Description
TEXAS
Zip Code
75252
Issuer Phone Number
2143066218
Jurisdiction Of Inc
DELAWARE
Issuer Previous Name List
None
Edgar Previous Name List
None
Entity Type
Corporation

Year Of Inc

Within Five Years
true
Value
2019

Related Person Info

Related Person Name

First Name
Lucas
Last Name
Rodriguez

Related Person Address

Street1
17217 Waterview Parkway Suite 1.202
City
Dallas
State Or Country
TX
State Or Country Description
TEXAS
Zip Code
75252
Related Person Relationship List Relationship
Director

Related Person Name

First Name
Tyler
Last Name
Brous

Related Person Address

Street1
3889 Maple Avenue, Suite 125
City
Dallas
State Or Country
TX
State Or Country Description
TEXAS
Zip Code
75219
Related Person Relationship List Relationship
Director

Related Person Name

First Name
Scott
Last Name
Dax

Related Person Address

Street1
3 Quail Drive
City
Landenberg
State Or Country
PA
State Or Country Description
PENNSYLVANIA
Zip Code
19350
Related Person Relationship List Relationship
Director

Related Person Name

First Name
David
Last Name
Genecov

Related Person Address

Street1
11970 North Central Expressway Suite 270
City
Dallas
State Or Country
TX
State Or Country Description
TEXAS
Zip Code
75243
Related Person Relationship List Relationship
Director

Related Person Name

First Name
David
Last Name
Hitt II

Related Person Address

Street1
4237 Helmsley Ln
City
Plano
State Or Country
TX
State Or Country Description
TEXAS
Zip Code
75093
Related Person Relationship List Relationship
Director

Related Person Name

First Name
Dennis
Last Name
Robbins

Related Person Address

Street1
1104 Morningstar Trail
City
Richardson
State Or Country
TX
State Or Country Description
TEXAS
Zip Code
75081
Related Person Relationship List Relationship
Director

Related Person Name

First Name
Pat
Last Name
Confalone

Related Person Address

Street1
303 Centennial Circle
City
Wilmington
State Or Country
DE
State Or Country Description
DELAWARE
Zip Code
19807
Related Person Relationship List Relationship
Director

Related Person Name

First Name
Brent
Last Name
Duncan

Related Person Address

Street1
2710 Sir Bedivere Ln
City
Lewisville
State Or Country
TX
State Or Country Description
TEXAS
Zip Code
75056
Related Person Relationship List Relationship
Director

Related Person Name

First Name
John D.
Last Name
Harkey, Jr.

Related Person Address

Street1
12200 North Stemmons Freeway Suite 100
City
Dallas
State Or Country
TX
State Or Country Description
TEXAS
Zip Code
75234
Related Person Relationship List Relationship
Director

Related Person Name

First Name
Perry
Last Name
Molinoff

Related Person Address

Street1
10 Blue Heron Pond Rd
City
Johns Island
State Or Country
SC
State Or Country Description
SOUTH CAROLINA
Zip Code
29455
Related Person Relationship List Relationship
Director

Offering Data

Industry Group Industry Group Type
Pharmaceuticals
Issuer Size Revenue Range
Decline to Disclose
Federal Exemptions Exclusions Item
06b

Type Of Filing

New Or Amendment Is Amendment
false
Date Of First Sale
2019-04-04
Duration Of Offering More Than One Year
false
Types Of Securities Offered Is Equity Type
true

Business Combination Transaction

Is Business Combination Transaction
false
Minimum Investment Accepted
600

Offering Sales Amounts

Total Offering Amount
8000000
Total Amount Sold
8000000
Total Remaining
0

Investors

Has Non Accredited Investors
false
Total Number Already Invested
24

Sales Commissions Finders Fees

Sales Commissions Dollar Amount
0
Finders Fees Dollar Amount
0

Use Of Proceeds

Gross Proceeds Used Dollar Amount
0

Signature Block

Authorized Representative
false

Signature

Issuer Name
CerSci Therapeutics Inc.
Signature Name
Lucas Rodriguez
Name Of Signer
Lucas Rodriguez
Signature Title
Chief Executive Officer of Issuer
Signature Date
2019-10-07
Additional Files
FileSequenceDescriptionTypeSize
0001790478-19-000001.txt   Complete submission text file   12609

© 2019 SEC.report
SEC CFR Title 17 of the Code of Federal Regulations.